The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Together with Transplant International, we are pleased to announce that applications are now open for the 2026 edition of the Editorial Fellowship programme, a twelve-month programme for 5 transplant fellows or early career professionals with an interest in research, education, medical editing, and scholarly writing. The Editorial Fellowship will offer the opportunity to connect more closely with the ESOT community
Receiving a transplant represents hope, but long-term success depends on far more than surgery alone. The ESOT–Takeda collaboration, outlined in the September 2025 report Enhancing Post-Transplant Care, demonstrates how person-centred care and infectious disease educationcan reshape outcomes across Europe. Moving Beyond the Organ Post-transplant care must address: Infection risk (including CMV and multidrug-resistant organisms) Emotional and psychological adaptation Patient literacy and
The European Society for Organ Transplantation (ESOT), in collaboration with Therakos, has published a new report examining the current status, clinical potential, and future directions of Extracorporeal Photopheresis (ECP) in solid organ transplantation. Allograft rejection remains a major cause of long-term graft failure and patient morbidity following transplantation. While conventional immunosuppressive therapies have significantly improved short-term outcomes, they are
This achievement exemplifies the impact of data-driven, collaborative science in addressing complex clinical challenges. It sets a new benchmark for endpoint innovation, not only in transplantation, but across clinical research more broadly.
#ClinicalResearch #Innovation #PoweredByESOT
We are pleased to announce that the following ESOT Sections and Committees launched a call for nominations for new Board members: EKITA, ELITA, VCA, BSC, YPT
The Vascularized Composite Allotransplantation (VCA) Section is pleased to announce a call for nominations for four new Board members. The elected members will serve two years (2026-2028) with a maximum of two consecutive terms. One of the four positions is reserved for a professional working in the field of uterus transplantation.
